piribedil has been researched along with Depressive Disorder in 6 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "With the exception of Parkinson's disease, there is little evidence that treatments which decrease DA function are potent inducers of depression, but it is argued that such a relationship might not necessarily be expected." | 2.36 | Dopamine and depression: a review of recent evidence. I. Empirical studies. ( Willner, P, 1983) |
| "Piribedil is a relatively selective dopamine agonist with moderate antidepressant activity." | 1.27 | Neuroendocrine effects of the dopamine agonist piribedil in depressed patients. ( Ballenger, JC; Gold, PW; Joffe, RT; Post, RM; Rakita, R; Rebar, R, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willner, P | 1 |
| Jimerson, DC | 1 |
| Cutler, NR | 1 |
| Post, RM | 3 |
| Rey, A | 1 |
| Gold, PW | 2 |
| Brown, GM | 1 |
| Bunney, WE | 1 |
| Reus, VI | 1 |
| Lake, CR | 1 |
| Mouret, J | 2 |
| Lemoine, P | 2 |
| Minuit, MP | 2 |
| Robelin, N | 1 |
| Joffe, RT | 1 |
| Ballenger, JC | 1 |
| Rebar, R | 1 |
| Rakita, R | 1 |
1 review available for piribedil and Depressive Disorder
| Article | Year |
|---|---|
Dopamine and depression: a review of recent evidence. I. Empirical studies.
Topics: Amphetamine; Antipsychotic Agents; Brain; Bromocriptine; Depressive Disorder; Dihydroxyphenylalanine | 1983 |
1 trial available for piribedil and Depressive Disorder
| Article | Year |
|---|---|
[L-tyrosine cures, immediate and long term, dopamine-dependent depressions. Clinical and polygraphic studies].
Topics: Clinical Trials as Topic; Depressive Disorder; Dopamine; Humans; Piribedil; Sleep; Sleep, REM; Tyros | 1988 |
4 other studies available for piribedil and Depressive Disorder
| Article | Year |
|---|---|
Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects.
Topics: Adult; Age Factors; Apomorphine; Bipolar Disorder; Depressive Disorder; Female; Growth Hormone; Huma | 1984 |
Effect of piribedil (ET-495) on plasma norepinephrine: relationship to antidepressant response.
Topics: Antidepressive Agents; Blood Pressure; Depressive Disorder; Female; Heart Rate; Humans; Male; Norepi | 1980 |
[Polygraphic, clinical and therapeutic markers of dopamine-dependent depressions].
Topics: Adult; Depressive Disorder; Dopamine; Humans; Middle Aged; Neurophysiology; Piperazines; Piribedil; | 1987 |
Neuroendocrine effects of the dopamine agonist piribedil in depressed patients.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Female; Humans; Male; Middle Aged; Piperazines; Piribe | 1986 |